The Effects Of The 32-bp CCR-5 Deletion On HIV Transmission And ...
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Wiley Full text links Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- Publication types
- MeSH terms
- Substances
- LinkOut - more resources
Abstract
The chemokine receptor CCR5 is an important co-receptor for cell fusion. A 32-bp deletion of the CCR5 gene, leading to complete absence of functional CCR5 expression, has been associated with resistance to human immunodeficiency virus (HIV) infection in homozygotes and slower HIV disease progression in heterozygotes. The objectives of this study were to assess the effects of this 32-bp deletion on transmission of HIV infection and on HIV disease progression in haemophilic individuals. Six HIV-negative patients from our centre, known to have been exposed to infectious factor VIII concentrates, have been analysed. Three of these patients possess the CCR5 32-bp deletion, two patients being homozygous. The presence of the CCR5 32-bp gene deletion has also been analysed in 71 HIV-positive patients. In this group of patients, there was a lower than expected incidence of the 32-bp deletion. Those who possess the 32-bp deletion progress to AIDS more slowly than those who do not (P = 0.05, log-rank test). Rates of CD4 loss were slower in those heterozygous for the gene deletion. We confirm that heterozygosity for the 32-bp gene deletion in CCR5 is partially protective against initial infection with HIV. In those heterozygous patients who became infected with HIV, disease progression was slower.
PubMed Disclaimer
Publication types
- Research Support, Non-U.S. Gov't Actions
- Search in PubMed
- Search in MeSH
- Add to Search
MeSH terms
- Acquired Immunodeficiency Syndrome / genetics Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Acquired Immunodeficiency Syndrome / immunology Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- CD4 Lymphocyte Count Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Disease Progression Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Follow-Up Studies Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Gene Deletion* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- HIV Infections / genetics Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- HIV Infections / immunology Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- HIV Infections / transmission* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Hemophilia A / genetics Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Hemophilia A / immunology Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Hemophilia A / virology* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Heterozygote Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Immunity, Innate / genetics Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Proportional Hazards Models Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- RNA, Viral / analysis Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Receptors, CCR5 / genetics* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Survival Rate Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- RNA, Viral Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Receptors, CCR5 Actions
- Search in PubMed
- Search in MeSH
- Add to Search
LinkOut - more resources
Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Wiley [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To - Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Từ khóa » Bp X 32
-
Dầu Tuabin BP Turbinol X 32 - Dầu Công Nghiệp | Dau Cong Nghiep
-
Dầu Tuabin Chính Hãng BP Turbinol X32 - Dầu Thủy Lực, Dau Thuy Luc
-
Dầu Tuabin BP Turbinol X 32
-
Nhớt BP Turbinol X 32
-
Dầu Tuabin BP Turbinol X32 | Dầu Thủy Lực | Dầu Công Nghiệp
-
[PDF] BP Hydraulic Oil 32
-
[PDF] Turbinol X-EP™ 32F, 46F & 68F - BP
-
CONNECTOR BP 32 AMP INS SING SCREW 100PK - CNW
-
2302670 | PHOENIX 1 X 32 WAY,3.0MTR INPUT CABLE - BPX
-
BP FITTING, M BAYONET, 5/32 TUBE | Web Channel | United States
-
Aspirin Tablets BP 300mg X32 - Williams Medical Supplies
-
Paracetamol Tablets BP 500mg X 32 - Denka U.K
-
Selecting A Cuff Size | Target:BP